SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:kth-309166"
 

Search: id:"swepub:oai:DiVA.org:kth-309166" > Reconditioning the ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Peters, S. (author)

Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-04-15
  • Springer Nature,2021
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:kth-309166
  • https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-309166URI
  • https://doi.org/10.1007/s13311-021-01045-2DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:146429666URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • QC 20220309
  • Adult neurogenesis is a target for brain rejuvenation as well as regeneration in aging and disease. Numerous approaches showed efficacy to elevate neurogenesis in rodents, yet translation into therapies has not been achieved. Here, we introduce a novel human TGFβ-RII (Transforming Growth Factor—Receptor Type II) specific LNA-antisense oligonucleotide (“locked nucleotide acid”—“NVP-13”), which reduces TGFβ-RII expression and downstream receptor signaling in human neuronal precursor cells (ReNcell CX® cells) in vitro. After we injected cynomolgus non-human primates repeatedly i.th. with NVP-13 in a preclinical regulatory 13-week GLP-toxicity program, we could specifically downregulate TGFβ-RII mRNA and protein in vivo. Subsequently, we observed a dose-dependent upregulation of the neurogenic niche activity within the hippocampus and subventricular zone: human neural progenitor cells showed significantly (up to threefold over control) enhanced differentiation and cell numbers. NVP-13 treatment modulated canonical and non-canonical TGFβ pathways, such as MAPK and PI3K, as well as key transcription factors and epigenetic factors involved in stem cell maintenance, such as MEF2A and pFoxO3. The latter are also dysregulated in clinical neurodegeneration, such as amyotrophic lateral sclerosis. Here, we provide for the first time in vitro and in vivo evidence for a novel translatable approach to treat neurodegenerative disorders by modulating neurogenesis.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Kuespert, S. (author)
  • Wirkert, E. (author)
  • Heydn, R. (author)
  • Jurek, B. (author)
  • Johannesen, S. (author)
  • Hsam, O. (author)
  • Korte, S. (author)
  • Ludwig, F. T. (author)
  • Mecklenburg, L. (author)
  • Mrowetz, H. (author)
  • Altendorfer, B. (author)
  • Poupardin, R. (author)
  • Petri, S. (author)
  • Thal, D. R. (author)
  • Hermann, A. (author)
  • Weishaupt, J. H. (author)
  • Weis, J. (author)
  • Aksoylu, I. S.Karolinska Institutet (author)
  • Lewandowski, SebastianKarolinska Institutet,KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1d4y8tu (author)
  • Aigner, L. (author)
  • Bruun, T. -H (author)
  • Bogdahn, U. (author)
  • Karolinska InstitutetAffinitets-proteomik (creator_code:org_t)

Related titles

  • In:Neurotherapeutics: Springer Nature18:3, s. 1963-19791933-72131878-7479

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view